olopatadine
Opatanol · ATC code S01GX09
Also known as: Olopatadin · Brand names: Opatanol, Olopatadin Micro Labs, Olopatadin Unimed Pharma, Alltrevo, Olopatadin Actrevo, Olopatadin Juta, Olopatadin Otc, Optilegra, Dupatin, Ofnol, Oladin %, Pallada, Prurivia
- Key facts
- Active substance
- olopatadine
- ATC code
- S01GX09
- Authorisation
- centrally authorised across the EU (EMA)
- Dosage forms
- Opatanol 1 mg/mL eye drops, solution
- Marketing authorisation holder
- Novartis Europharm Limited
- Information as of
- 2026-10-27
Key facts
Olopatadine is an antiallergic/antihistaminic eye drop used to treat ocular signs and symptoms of seasonal allergic conjunctivitis.
What it is used for
- Ocular signs and symptoms of seasonal allergic conjunctivitis
Dosing
- One drop in the conjunctival sac of the affected eye(s) twice daily (8 hourly)
- Treatment may be maintained for up to four months if necessary
- Children three years and older: same dose as adults; no adjustment in the elderly
- With other eye medicines, five minutes between applications; eye ointments last
Contraindications
- Hypersensitivity to the active substance or any excipient
Important warnings
- Absorbed systemically; discontinue if serious reactions or hypersensitivity occur
- Contains benzalkonium chloride: eye irritation, punctate or toxic ulcerative keratopathy possible
- Contact lenses removed before use and reinserted after at least 15 minutes; soft lenses may discolour
Side effects
- Common: eye pain, eye irritation, dry eye, abnormal sensation in eyes, headache, dysgeusia
- Uncommon: rhinitis, dizziness, hypoaesthesia
- No serious adverse reactions in clinical studies
Interactions
- No interaction studies; metabolic interactions are considered unlikely
Pregnancy and breastfeeding
- Not recommended during pregnancy and in women of childbearing potential not using contraception
- Should not be used during breast-feeding
Summary of the official product information, written with AI (Claude, Anthropic) on 2026-10-28. Every number was checked automatically against the original text. Not reviewed by a physician – the full official text is authoritative.
Common questions – ask Medelix
For patients
Package leaflet, verbatim
Authorisation and brand names by country
Medicines with exactly this active-substance composition, as listed in the national registers – alphabetical and without ranking. Whether a product is currently available is not shown here.
EU – centrally authorised (all member states)
- OpatanolNovartis Europharm Limited · EMEA/H/C/000407
Source: European Medicines Agency (EMA), product information
Austria
- Olopatadin Micro LabsMicro Labs Gmbh · 1 register entry
- Olopatadin Unimed PharmaUnimed Pharma Spol.S R.O. · 1 register entry
Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28
Germany
- AlltrevoActrevo Gmbh · 1 register entry
- Olopatadin ActrevoActrevo Gmbh · 1 register entry
- Olopatadin JutaJuta Pharma Gmbh · 1 register entry
- Olopatadin Micro LabsMicro Labs Gmbh · 1 register entry
- Olopatadin OtcJuta Pharma Gmbh · 2 register entries
- OptilegraA. Nattermann & Cie. Gmbh · 1 register entry
Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28
Turkey
- DupatinDEVA HOLDİNG A.Ş. · 3 register entries
- OfnolABDİ İBRAHİM İLAÇ SAN. VE TİC. A.Ş. · 3 register entries
- Oladin %BİLİM İLAÇ SAN. VE TİC. A.Ş. · 1 register entry
- PalladaWORLD MEDICINE İLAÇ SAN. VE TİC. A.Ş. · 2 register entries
- PruriviaROMPHARM İLAÇ SAN. VE TİC. LTD. ŞTİ. · 2 register entries
Source: TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, as of 2026-10-16
Brand names in 24 more European countries
- Bulgaria
- Оловижън, Олопатадин Унимед Фарма, Паллада
- Croatia
- Olopatadin
- Cyprus
- Alopatan, Olopatadine Rafarm
- Czechia
- Olopatadine Unimed Pharma, Olopatidine Olikla
- Denmark
- Olopatadin Brown & Burk, Olopatadin Evolan, Olopatadin Juta, Olopatadin Orifarm, Olopatadine Sandoz, Olpalan, Toredin
- Estonia
- Olopatadine Unimed Pharma
- Greece
- Alopatan, Olopatadine Rafarm
- Hungary
- Olopatadine Unimed Pharma
- Iceland
- Opatanol
- Ireland
- Olopatadine Brown & Burk
- Italy
- Calmira®, Olonet, Olopatadina Farto
- Latvia
- Olopatadine Unimed Pharma
- Liechtenstein
- Opatanol
- Lithuania
- Olopatadine Unimed Pharma
- Malta
- Olopatadine Unimed Pharma
- Netherlands
- Olopatadine Brown & Burk, Optamont
- Norway
- Olopatadine Sandoz, Opatanol, Optamont, Toredin
- Poland
- Oftahist, Olodon Free, Olopatadine Brown & Burk, Olopatadine Unimed Pharma, Starazolin Alergia
- Portugal
- Olopatadina Stallpharma
- Romania
- Olopatadina Brown & Burk, Olopatadină Rompharm, Olopatadină Unimed Pharma
- Slovakia
- Olopatadine Olikla, Olopatadine Unimed Pharma
- Slovenia
- Olopatadin Unimed Pharma
- Spain
- Apadin, Olopatadina Abamed, Olopatadina Juta
- Sweden
- Olopatadin Evolan, Olopatadin Orifarm, Olopatadine Brown & Burk, Olopatadine Sandoz, Olpalan, Optamont, Toredin
EMA – Article 57 product data (EU/EEA), 2026-10-28
Medelix receives no money from pharmaceutical companies. Brand names are listed alphabetically and without ranking.
Another question about this substance?
Medelix answers clinical questions from guidelines, studies and product information – every claim with its source.
Sources
- European Medicines Agency. Opatanol – EPAR, Product Information (OF THE TEXT Detailed information on this medicinal product i). 2026-10-27. https://www.ema.europa.eu/en/documents/product-information/opatanol-epar-product-information_en.pdf
- EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, 2026-10-16. https://www.titck.gov.tr/dinamikmodul/85
Editorial: Medelix editorial team · last updated 2026-10-27 · How these pages are made · Report an error
Source: European Medicines Agency (EMA), product information. Not advertising, not a treatment recommendation. For questions about your own treatment, ask your doctor or pharmacist.